Arkolith/Insider Trading/GMTX/Form 4

Gemayel Georges

See Remarks, DirectorGemini Therapeutics, Inc. /DE (GMTX) · full profile →Form 4 · filed Nov 16, 2021
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
0 non-derivative · 2 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 15, 2021Grant(A)17K—$017K
Nov 15, 2021Grant(A)24K—$024K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-21-044718) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML